Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02509078 · ClinicalTrials.gov registry record · Phase 3
Reevaluation Of Systemic Early Neuromuscular Blockade
A Phase 3 study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,008
- Enrollment target
NCT02509078: Completed Phase 3 study, sponsored by Massachusetts General Hospital.
NCT02509078 is a Phase 3 study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 1,008 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (31% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02509078, a Phase 3 study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,008 participants
- Enrollment target
Study Summary
This study evaluates whether giving a neuromuscular blocker (skeletal muscle relaxant) to a patient with acute respiratory distress syndrome will improve survival. Half of the patients will receive a neuromuscular blocker for two days and in the other half the use of neuromuscular blockers will be discouraged.
Primary Outcome
The percentage of subjects alive at study day 90. Those subjects discharged home prior to day 90 were counted as alive at day 90.
Interventions
- DRUG Cisatracurium Besylate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,008 participants |
| Start Date | 2016-01-04 |
| Est. Completion | 2019-04-04 |
| Phase | Phase 3 |
What the finished NCT02509078 record still lists
NCT02509078 is an interventional study that assigns participants to a tested intervention. Its 1,008 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (31% higher).
The record links to 0 conditions, and to 1 intervention - of which Cisatracurium Besylate is the first listed.
NCT02509078 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02509078 about?
NCT02509078 is a clinical study titled "Reevaluation Of Systemic Early Neuromuscular Blockade". This study evaluates whether giving a neuromuscular blocker (skeletal muscle relaxant) to a patient with acute respiratory distress syndrome will improve survival. Half of the patients will receive a neuromuscular blocker for two days and in the other half the use of neuromuscular blockers will be d...
What is the current status of trial NCT02509078?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,008 participants. The study started on 2016-01-04. Estimated completion is 2019-04-04.
What interventions are being tested in trial NCT02509078?
The interventions under investigation include: Cisatracurium Besylate (DRUG).
Who is sponsoring clinical trial NCT02509078?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02509078's enrollment target sits among peer trials
1,008 295th of 2000 higher than 1,706 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07191782 · 1,008 participants · NA
Examining the Efficacy of the PRAISE With Coaching Program
- NCT04389632 · 1,006 participants · Phase 1
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- NCT06146738 · 1,015 participants
The PALSUR-study: Palliative Care Versus Surgery in High-grade Glioma Patients (ENCRAM 2203)
- NCT06207864 · 1,001 participants · NA
Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI